Related Experiment Videos
Development and validation of a CGH microarray for clinical cytogenetic diagnosis
Sau W Cheung1, Chad A Shaw, Wei Yu
1Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Summary
This study introduces a new microarray for diagnosing chromosomal disorders, offering high accuracy in detecting deletions and duplications. It serves as a valuable tool for genetic clinics, complementing existing diagnostic methods.
Area of Science:
- Genomics
- Clinical Diagnostics
- Cytogenetics
Background:
- Chromosomal abnormalities are a major cause of genetic disorders.
- Comparative genomic hybridization (CGH) is a powerful technique for detecting copy number variations.
- Existing methods like FISH have limitations in scope and detection capabilities.
Purpose of the Study:
- To develop and validate a microarray for clinical diagnosis of chromosomal disorders.
- To utilize large insert genomic DNA clones for comparative genomic hybridization (CGH).
- To create a comprehensive tool for identifying a wide range of genomic imbalances.
Main Methods:
- A microarray was designed with 362 FISH-verified clones targeting known human genomic disorders and subtelomeric regions.
- Chromosome microarray analysis (CMA) was tested on DNA from 25 patients using a masked approach.
- A custom R statistical programming package was developed for data analysis.
Main Results:
- CMA results showed high concordance with previous cytogenetic and FISH findings.
- Clone-by-clone analysis achieved 96.7% sensitivity and 99.1% specificity.
- The array effectively detected duplications missed by metaphase FISH and facilitated confirmation.
Conclusions:
- The developed microarray is a promising alternative to FISH for specific applications.
- It enables simultaneous analysis of numerous deletion and duplication syndromes.
- Limitations include lack of uniform chromosomal coverage and inability to detect balanced rearrangements or low-level mosaicism.